Sellas Life Sciences Group Inc
SLS
$13.86+1.17%
End of day · as of Sep 5, 2026, 8:45 AM ET
Mkt cap
$1.62B
EV/Sales
N/A
P/E ratio
N/A
FY2023 Revenue
N/A
EPS (H1 2026)
$-0.10
Gross Margin (FY2023)
N/A
Profit Margin (FY2023)
N/A
Beta
2.53
Div yield
N/A
Sector
Healthcare
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported SLS revenue for 2023-12-31 was $0. Net income was -$37.3M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. SLS currently screens at market cap $1.62B.
Use this SLS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SLS income, balance, and cash tables.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company in the Healthcare sector.
Latest cached Sellas Life Sciences Group Inc (SLS) net income for Dec 31, 2023 was -$37.3M. Statements: https://lician.com/financials/sls
Sellas Life Sciences Group Inc (SLS) market capitalization is $1.62B on the latest cached snapshot.
Sellas Life Sciences Group Inc (SLS) cached previous close $13.70; day range $13.43 – $14.14; volume 4,469,036. Session quote: https://lician.com/quote/sls
Sellas Life Sciences Group Inc (SLS) latest cached earnings event is "SLS earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SLS filing is 8-K · Jul 27, 2026. Filings: https://lician.com/sec/sls